Association of ERAP1 and ERAP2 gene polymorphisms and ERAP2 protein with the susceptibility and severity of rheumatoid arthritis in the Ukrainian population

IntroductionRheumatoid arthritis (RA) is a long-term autoimmune disorder that primarily affects joints. Although RA is chiefly associated with HLA class II, nevertheless some HLA class I associations have also been observed. These molecules present antigenic peptides to CD8+ T lymphocytes and natura...

Full description

Saved in:
Bibliographic Details
Main Authors: Iryna Kril, Andrzej Wiśniewski, Agnieszka Tarnowska, Khrystyna Lishchuk-Yakymovych, Yaryna Bojko, Piotr Kuśnierczyk, Valentyna V. Chopyak, Izabela Nowak
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1519159/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832592664219877376
author Iryna Kril
Iryna Kril
Andrzej Wiśniewski
Agnieszka Tarnowska
Khrystyna Lishchuk-Yakymovych
Yaryna Bojko
Piotr Kuśnierczyk
Valentyna V. Chopyak
Izabela Nowak
author_facet Iryna Kril
Iryna Kril
Andrzej Wiśniewski
Agnieszka Tarnowska
Khrystyna Lishchuk-Yakymovych
Yaryna Bojko
Piotr Kuśnierczyk
Valentyna V. Chopyak
Izabela Nowak
author_sort Iryna Kril
collection DOAJ
description IntroductionRheumatoid arthritis (RA) is a long-term autoimmune disorder that primarily affects joints. Although RA is chiefly associated with HLA class II, nevertheless some HLA class I associations have also been observed. These molecules present antigenic peptides to CD8+ T lymphocytes and natural killer cells. HLA-I molecules bind their peptide cargo (8–10 amino acids long) in the endoplasmic reticulum. Peptides longer than 10 amino acids are trimmed by the endoplasmic reticulum aminopeptidases ERAP1 and ERAP2 to fit the peptide binding groove of the HLA-I molecule. Here, we investigated the possible association of ERAP1 and ERAP2 polymorphisms with RA, and also any possible correlation between serum levels of the ERAP2 protein with disease severity.MethodsWe used Real-Time PCR to genotype ERAP1 and ERAP2 and ELISA test to detect ERAP2 protein.ResultsWe found significant associations of ERAP1 rs30187, rs27044, and rs26618, as well as ERAP2 rs2248374, with susceptibility to RA. ERAP1 rs26653 and ERAP2 rs2248374 were also associated with the Disease Activity Score (DAS28), and some polymorphisms were also associated with anti-citrullinated protein or anti-mutated citrullinated vimentin antibodies. RA patients secreted higher concentrations of ERAP2 than controls. Patients with mild disease activity (DAS28 < 3.2) released a concentration of ERAP2 four times lower than that of patients with severe disease activity (DAS28 > 5.1). We detected a higher level of ERAP2 in rheumatoid factor (RF)-positive patients than in RF-negative patients. ERAP2 concentration above 5.85 ng/mL indicated a severe phase of RA.ConclusionsSome ERAP1 and ERAP2 polymorphisms seem to be related to susceptibility to RA or the severity of the disease. The ERAP2 protein tested in serum could be a valuable biomarker of RA severity.
format Article
id doaj-art-b3577003764d4146aeb1d52ec40adb51
institution Kabale University
issn 1664-3224
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-b3577003764d4146aeb1d52ec40adb512025-01-21T05:43:37ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-01-011510.3389/fimmu.2024.15191591519159Association of ERAP1 and ERAP2 gene polymorphisms and ERAP2 protein with the susceptibility and severity of rheumatoid arthritis in the Ukrainian populationIryna Kril0Iryna Kril1Andrzej Wiśniewski2Agnieszka Tarnowska3Khrystyna Lishchuk-Yakymovych4Yaryna Bojko5Piotr Kuśnierczyk6Valentyna V. Chopyak7Izabela Nowak8Department of Clinical Immunology and Allergology, Danylo Halytsky Lviv National Medical University, Lviv, UkraineLaboratory of Immunogenetics and Tissue Immunology, Hirszfeld Institute of Immunology and Experimental Therapy Polish Academy of Sciences, Wrocław, PolandLaboratory of Immunogenetics and Tissue Immunology, Hirszfeld Institute of Immunology and Experimental Therapy Polish Academy of Sciences, Wrocław, PolandLaboratory of Immunogenetics and Tissue Immunology, Hirszfeld Institute of Immunology and Experimental Therapy Polish Academy of Sciences, Wrocław, PolandDepartment of Clinical Immunology and Allergology, Danylo Halytsky Lviv National Medical University, Lviv, UkraineDepartment of Clinical Immunology and Allergology, Danylo Halytsky Lviv National Medical University, Lviv, UkraineLaboratory of Immunogenetics and Tissue Immunology, Hirszfeld Institute of Immunology and Experimental Therapy Polish Academy of Sciences, Wrocław, PolandDepartment of Clinical Immunology and Allergology, Danylo Halytsky Lviv National Medical University, Lviv, UkraineLaboratory of Immunogenetics and Tissue Immunology, Hirszfeld Institute of Immunology and Experimental Therapy Polish Academy of Sciences, Wrocław, PolandIntroductionRheumatoid arthritis (RA) is a long-term autoimmune disorder that primarily affects joints. Although RA is chiefly associated with HLA class II, nevertheless some HLA class I associations have also been observed. These molecules present antigenic peptides to CD8+ T lymphocytes and natural killer cells. HLA-I molecules bind their peptide cargo (8–10 amino acids long) in the endoplasmic reticulum. Peptides longer than 10 amino acids are trimmed by the endoplasmic reticulum aminopeptidases ERAP1 and ERAP2 to fit the peptide binding groove of the HLA-I molecule. Here, we investigated the possible association of ERAP1 and ERAP2 polymorphisms with RA, and also any possible correlation between serum levels of the ERAP2 protein with disease severity.MethodsWe used Real-Time PCR to genotype ERAP1 and ERAP2 and ELISA test to detect ERAP2 protein.ResultsWe found significant associations of ERAP1 rs30187, rs27044, and rs26618, as well as ERAP2 rs2248374, with susceptibility to RA. ERAP1 rs26653 and ERAP2 rs2248374 were also associated with the Disease Activity Score (DAS28), and some polymorphisms were also associated with anti-citrullinated protein or anti-mutated citrullinated vimentin antibodies. RA patients secreted higher concentrations of ERAP2 than controls. Patients with mild disease activity (DAS28 < 3.2) released a concentration of ERAP2 four times lower than that of patients with severe disease activity (DAS28 > 5.1). We detected a higher level of ERAP2 in rheumatoid factor (RF)-positive patients than in RF-negative patients. ERAP2 concentration above 5.85 ng/mL indicated a severe phase of RA.ConclusionsSome ERAP1 and ERAP2 polymorphisms seem to be related to susceptibility to RA or the severity of the disease. The ERAP2 protein tested in serum could be a valuable biomarker of RA severity.https://www.frontiersin.org/articles/10.3389/fimmu.2024.1519159/fullrheumatoid arthritisMHC I classERAP1ERAP2single nucleotide polymorphisms
spellingShingle Iryna Kril
Iryna Kril
Andrzej Wiśniewski
Agnieszka Tarnowska
Khrystyna Lishchuk-Yakymovych
Yaryna Bojko
Piotr Kuśnierczyk
Valentyna V. Chopyak
Izabela Nowak
Association of ERAP1 and ERAP2 gene polymorphisms and ERAP2 protein with the susceptibility and severity of rheumatoid arthritis in the Ukrainian population
Frontiers in Immunology
rheumatoid arthritis
MHC I class
ERAP1
ERAP2
single nucleotide polymorphisms
title Association of ERAP1 and ERAP2 gene polymorphisms and ERAP2 protein with the susceptibility and severity of rheumatoid arthritis in the Ukrainian population
title_full Association of ERAP1 and ERAP2 gene polymorphisms and ERAP2 protein with the susceptibility and severity of rheumatoid arthritis in the Ukrainian population
title_fullStr Association of ERAP1 and ERAP2 gene polymorphisms and ERAP2 protein with the susceptibility and severity of rheumatoid arthritis in the Ukrainian population
title_full_unstemmed Association of ERAP1 and ERAP2 gene polymorphisms and ERAP2 protein with the susceptibility and severity of rheumatoid arthritis in the Ukrainian population
title_short Association of ERAP1 and ERAP2 gene polymorphisms and ERAP2 protein with the susceptibility and severity of rheumatoid arthritis in the Ukrainian population
title_sort association of erap1 and erap2 gene polymorphisms and erap2 protein with the susceptibility and severity of rheumatoid arthritis in the ukrainian population
topic rheumatoid arthritis
MHC I class
ERAP1
ERAP2
single nucleotide polymorphisms
url https://www.frontiersin.org/articles/10.3389/fimmu.2024.1519159/full
work_keys_str_mv AT irynakril associationoferap1anderap2genepolymorphismsanderap2proteinwiththesusceptibilityandseverityofrheumatoidarthritisintheukrainianpopulation
AT irynakril associationoferap1anderap2genepolymorphismsanderap2proteinwiththesusceptibilityandseverityofrheumatoidarthritisintheukrainianpopulation
AT andrzejwisniewski associationoferap1anderap2genepolymorphismsanderap2proteinwiththesusceptibilityandseverityofrheumatoidarthritisintheukrainianpopulation
AT agnieszkatarnowska associationoferap1anderap2genepolymorphismsanderap2proteinwiththesusceptibilityandseverityofrheumatoidarthritisintheukrainianpopulation
AT khrystynalishchukyakymovych associationoferap1anderap2genepolymorphismsanderap2proteinwiththesusceptibilityandseverityofrheumatoidarthritisintheukrainianpopulation
AT yarynabojko associationoferap1anderap2genepolymorphismsanderap2proteinwiththesusceptibilityandseverityofrheumatoidarthritisintheukrainianpopulation
AT piotrkusnierczyk associationoferap1anderap2genepolymorphismsanderap2proteinwiththesusceptibilityandseverityofrheumatoidarthritisintheukrainianpopulation
AT valentynavchopyak associationoferap1anderap2genepolymorphismsanderap2proteinwiththesusceptibilityandseverityofrheumatoidarthritisintheukrainianpopulation
AT izabelanowak associationoferap1anderap2genepolymorphismsanderap2proteinwiththesusceptibilityandseverityofrheumatoidarthritisintheukrainianpopulation